In the search for effective treatments for sleep apnea, a new step has just been ... Genio by Nyxoah and Inspire. The Belgian company Nyxoah (specializing in sleep quality) has, in fact, developed ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... are other companies offering treatment for OSA, such as ResMed (RMD) and Inspire Medical Systems (INSP).

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

The company develops minimally invasive solutions for patients with obstructive sleep apnea ... expand Inspire’s total addressable market by causing more people with obesity to seek treatment ...

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...